{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:23:51Z","timestamp":1793820231140,"version":"4.6.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T00:00:00Z","timestamp":1718064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2314-B-006-038, 111-2314-B-006-077-MY3"],"award-info":[{"award-number":["MOST 110-2314-B-006-038, 111-2314-B-006-077-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW112-TDU-B-211\u2013124005"],"award-info":[{"award-number":["MOHW112-TDU-B-211\u2013124005"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-112A1-CACO-02232311"],"award-info":[{"award-number":["NHRI-112A1-CACO-02232311"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biomed Sci"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Ovarian carcinoma (OC) is a fatal malignancy, with most patients experiencing recurrence and resistance to chemotherapy. In contrast to hematogenous metastasizing tumors, ovarian cancer cells disseminate within the peritoneal cavity, especially the omentum. Previously, we reported omental crown-like structure (CLS) number is associated with poor prognosis of advanced-stage OC. CLS that have pathologic features of a dead or dying adipocyte was surrounded by several macrophages is well known a histologic hallmark for inflammatory adipose tissue. In this study, we attempted to clarify the interaction between metastatic ovarian cancer cells and omental CLS, and to formulate a therapeutic strategy for advanced-stage ovarian cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A three-cell (including OC cells, adipocytes and macrophages) coculture model was established to mimic the omental tumor microenvironment (TME) of ovarian cancer. Caspase-1 activity, ATP and free fatty acids (FFA) levels were detected by commercial kits. An adipocyte organoid model was established to assess macrophages migration and infiltration. In vitro and in vivo experiments were performed for functional assays and therapeutic effect evaluations. Clinical OC tissue samples were collected for immunochemistry stain and statistics analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In three-cell coculture model, OC cells-derived IL-6 and IL-8 could induce the occurrence of pyroptosis in omental adipocytes. The pyroptotic adipocytes release ATP to increase macrophage infiltration, release FFA into TME, uptake by OC cells to increase chemoresistance. From OC tumor samples study, we demonstrated patients with high gasdermin D (GSDMD) expression in omental adipocytes is highly correlated with chemoresistance and poor outcome in advanced-stage OC. In animal model, by pyroptosis inhibitor, DSF, effectively retarded tumor growth and prolonged mice survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Omental adipocyte pyroptosis may contribute the chemoresistance in advanced stage OC. Omental adipocytes could release FFA and ATP through the GSDMD-mediate pyroptosis to induce chemoresistance and macrophages infiltration resulting the poor prognosis in advanced-stage OC. Inhibition of adipocyte pyroptosis may be a potential therapeutic modality in advanced-stage OC with omentum metastasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12929-024-01051-4","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:02:17Z","timestamp":1718125337000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer"],"prefix":"10.1186","volume":"31","author":[{"given":"Chang-Ni","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ling","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsing-Fen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Yin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Han","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Ling","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Ru","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2698-4971","authenticated-orcid":false,"given":"Keng-Fu","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2021.08.011","volume":"77","author":"C Marchetti","year":"2021","unstructured":"Marchetti C, De Felice F, Romito A, Iacobelli V, Maria Sassu C, Corrado G, Ricci C, Scambia G, Fagotti A. Chemotherapy resistance in epithelial ovarian cancer: mechanisms and emerging treatments. Semin Cancer Biol. 2021;77:144\u201366. https:\/\/doi.org\/10.1016\/j.semcancer.2021.08.011.","journal-title":"Semin Cancer Biol"},{"issue":"11","key":"1051_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/S1470-2045(06)70939-1","volume":"7","author":"DS Tan","year":"2006","unstructured":"Tan DS, Agarwal R, Kaye SB. Mechanisms of transcoelomic metastasis in ovarian cancer. Lancet Oncol. 2006;7(11):925\u201334. https:\/\/doi.org\/10.1016\/S1470-2045(06)70939-1.","journal-title":"Lancet Oncol"},{"issue":"11","key":"1051_CR3","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/nm.2492","volume":"17","author":"KM Nieman","year":"2011","unstructured":"Nieman KM, Kenny HA, Penicka CV, Ladanyi A, Buell-Gutbrod R, Zillhardt MR, Romero IL, Carey MS, Mills GB, Hotamisligil GS, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth. Nat Med. 2011;17(11):1498\u2013503. https:\/\/doi.org\/10.1038\/nm.2492.","journal-title":"Nat Med"},{"issue":"12","key":"1051_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.3390\/biology9120474","volume":"9","author":"N Germain","year":"2020","unstructured":"Germain N, Dhayer M, Boileau M, Fovez Q, Kluza J, Marchetti P. Lipid metabolism and resistance to Anticancer Treatment. Biology (Basel). 2020;9(12):474. https:\/\/doi.org\/10.3390\/biology9120474.","journal-title":"Biology (Basel)"},{"issue":"5","key":"1051_CR5","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.3390\/curroncol28050359","volume":"28","author":"YL Liang","year":"2021","unstructured":"Liang YL, Lin CN, Tsai HF, Wu PY, Lin SH, Hong TM, Hsu KF. Omental Macrophagic Crown-like structures are Associated with Poor Prognosis in Advanced-Stage Serous Ovarian Cancer. Curr Oncol. 2021;28(5):4234\u201346. https:\/\/doi.org\/10.3390\/curroncol28050359.","journal-title":"Curr Oncol"},{"issue":"3","key":"1051_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cell.2016.03.009","volume":"165","author":"J Wang","year":"2016","unstructured":"Wang J, Kubes P. A Reservoir of mature cavity macrophages that can rapidly invade visceral organs to affect tissue repair. Cell. 2016;165(3):668\u201378. https:\/\/doi.org\/10.1016\/j.cell.2016.03.009.","journal-title":"Cell"},{"issue":"1","key":"1051_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","volume":"6","author":"P Yu","year":"2021","unstructured":"Yu P, Zhang X, Liu N, Tang L, Peng C, Chen X. Pyroptosis: mechanisms and diseases. Signal Transduct Target Ther. 2021;6(1):128. https:\/\/doi.org\/10.1038\/s41392-021-00507-5.","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"1051_CR8","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.7150\/thno.71086","volume":"12","author":"Z Rao","year":"2022","unstructured":"Rao Z, Zhu Y, Yang P, Chen Z, Xia Y, Qiao C, Liu W, Deng H, Li J, Ning P, et al. Pyroptosis in inflammatory diseases and cancer. Theranostics. 2022;12(9):4310\u201329. https:\/\/doi.org\/10.7150\/thno.71086.","journal-title":"Theranostics"},{"issue":"1","key":"1051_CR9","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41420-022-01101-6","volume":"8","author":"L Lu","year":"2022","unstructured":"Lu L, Zhang Y, Tan X, Merkher Y, Leonov S, Zhu L, Deng Y, Zhang H, Zhu D, Tan Y, et al. Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer. Cell Death Discov. 2022;8(1):338. https:\/\/doi.org\/10.1038\/s41420-022-01101-6.","journal-title":"Cell Death Discov"},{"issue":"6","key":"1051_CR10","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1093\/intimm\/dxs161","volume":"25","author":"Q Wang","year":"2013","unstructured":"Wang Q, Imamura R, Motani K, Kushiyama H, Nagata S, Suda T. Pyroptotic cells externalize eat-me and release find-me signals and are efficiently engulfed by macrophages. Int Immunol. 2013;25(6):363\u201372. https:\/\/doi.org\/10.1093\/intimm\/dxs161.","journal-title":"Int Immunol"},{"key":"1051_CR11","doi-asserted-by":"publisher","first-page":"1082165","DOI":"10.3389\/fimmu.2023.1082165","volume":"14","author":"Q Kong","year":"2023","unstructured":"Kong Q, Zhang Z. Cancer-associated pyroptosis: a new license to kill tumor. Front Immunol. 2023;14:1082165. https:\/\/doi.org\/10.3389\/fimmu.2023.1082165.","journal-title":"Front Immunol"},{"issue":"1","key":"1051_CR12","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","volume":"28","author":"SS Faria","year":"2021","unstructured":"Faria SS, Costantini S, de Lima VCC, de Andrade VP, Rialland M, Cedric R, Budillon A, Magalh\u00e3es KG. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer. J Biomed Sci. 2021;28(1):26. https:\/\/doi.org\/10.1186\/s12929-021-00724-8.","journal-title":"J Biomed Sci"},{"issue":"1","key":"1051_CR13","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1128\/JVI.65.1.473-478.1991","volume":"65","author":"CL Halbert","year":"1991","unstructured":"Halbert CL, Demers GW, Galloway DA. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol. 1991;65(1):473\u20138. https:\/\/doi.org\/10.1128\/JVI.65.1.473-478.1991.","journal-title":"J Virol"},{"issue":"24","key":"1051_CR14","first-page":"6077","volume":"55","author":"CY Chou","year":"1995","unstructured":"Chou CY, Shen MR, Wu SN. Volume-sensitive chloride channels associated with human cervical carcinogenesis. Cancer Res. 1995;55(24):6077\u201383.","journal-title":"Cancer Res"},{"issue":"8","key":"1051_CR15","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/cgt.2008.37","volume":"15","author":"KF Hsu","year":"2008","unstructured":"Hsu KF, Wu CL, Huang SC, Hsieh JL, Huang YS, Chen YF, Shen MR, Chung WJ, Chou CY, Shiau AL. Conditionally replicating E1B-deleted adenovirus driven by the squamous cell carcinoma antigen 2 promoter for uterine cervical cancer therapy. Cancer Gene Ther. 2008;15(8):526\u201334. https:\/\/doi.org\/10.1038\/cgt.2008.37.","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"1051_CR16","doi-asserted-by":"publisher","first-page":"100197","DOI":"10.1016\/j.xpro.2020.100197","volume":"1","author":"M Picon-Ruiz","year":"2020","unstructured":"Picon-Ruiz M, Marchal JA, Slingerland JM. Obtaining human breast adipose cells for breast Cancer cell co-culture studies. STAR Protoc. 2020;1(3):100197. https:\/\/doi.org\/10.1016\/j.xpro.2020.100197.","journal-title":"STAR Protoc"},{"issue":"46","key":"1051_CR17","doi-asserted-by":"publisher","first-page":"45777","DOI":"10.1074\/jbc.M301977200","volume":"278","author":"V Rotter","year":"2003","unstructured":"Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem. 2003;278(46):45777\u201384. https:\/\/doi.org\/10.1074\/jbc.M301977200.","journal-title":"J Biol Chem"},{"issue":"7","key":"1051_CR18","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.it.2017.03.002","volume":"38","author":"S Meza-Perez","year":"2017","unstructured":"Meza-Perez S, Randall TD. Immunological functions of the Omentum. Trends Immunol. 2017;38(7):526\u201336. https:\/\/doi.org\/10.1016\/j.it.2017.03.002.","journal-title":"Trends Immunol"},{"issue":"478","key":"1051_CR19","doi-asserted-by":"publisher","first-page":"eaau5758","DOI":"10.1126\/scitranslmed.aau5758","volume":"11","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Clark AK, Selth LA, Haynes VR, Lister N, Rebello R, Porter LH, Niranjan B, Whitby ST, Lo J, et al. Suppressing fatty acid uptake has therapeutic effects in preclinical models of prostate cancer. Sci Transl Med. 2019;11(478):eaau5758. https:\/\/doi.org\/10.1126\/scitranslmed.aau5758.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1051_CR20","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.cmet.2017.11.001","volume":"27","author":"T Wang","year":"2018","unstructured":"Wang T, Fahrmann JF, Lee H, Li YJ, Tripathi SC, Yue C, Zhang C, Lifshitz V, Song J, Yuan Y, et al. JAK\/STAT3-Regulated Fatty Acid \u03b2-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance. Cell Metab. 2018;27(1):136-e1505. https:\/\/doi.org\/10.1016\/j.cmet.2017.11.001.","journal-title":"Cell Metab"},{"issue":"13","key":"1051_CR21","doi-asserted-by":"publisher","first-page":"111044","DOI":"10.1016\/j.celrep.2022.111044","volume":"39","author":"YJ Li","year":"2022","unstructured":"Li YJ, Fahrmann JF, Aftabizadeh M, Zhao Q, Tripathi SC, Zhang C, Yuan Y, Ann D, Hanash S, Yu H. Fatty acid oxidation protects cancer cells from apoptosis by increasing mitochondrial membrane lipids. Cell Rep. 2022;39(13):111044. https:\/\/doi.org\/10.1016\/j.celrep.2022.111044.","journal-title":"Cell Rep"},{"issue":"10","key":"1051_CR22","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.7150\/ijbs.60292","volume":"17","author":"H Yan","year":"2021","unstructured":"Yan H, Luo B, Wu X, Guan F, Yu X, Zhao L, Ke X, Wu J, Yuan J. Cisplatin induces pyroptosis via activation of MEG3\/NLRP3\/caspase-1\/GSDMD pathway in Triple-negative breast Cancer. Int J Biol Sci. 2021;17(10):2606\u201321. https:\/\/doi.org\/10.7150\/ijbs.60292.","journal-title":"Int J Biol Sci"},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2407-11-210","volume":"11","author":"D Lane","year":"2011","unstructured":"Lane D, Matte I, Rancourt C, Pich\u00e9 A. Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients. BMC Cancer. 2011;11:210. https:\/\/doi.org\/10.1186\/1471-2407-11-210.","journal-title":"BMC Cancer"},{"issue":"5","key":"1051_CR24","first-page":"566","volume":"2","author":"I Matte","year":"2012","unstructured":"Matte I, Lane D, Laplante C, Rancourt C, Pich\u00e9 A. Profiling of cytokines in human epithelial ovarian cancer ascites. Am J Cancer Res. 2012;2(5):566\u201380.","journal-title":"Am J Cancer Res"},{"issue":"12","key":"1051_CR25","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.3390\/ijms20122927","volume":"20","author":"E Ghisoni","year":"2019","unstructured":"Ghisoni E, Imbimbo M, Zimmermann S, Valabrega G. Ovarian Cancer immunotherapy: turning up the heat. Int J Mol Sci. 2019;20(12):2927. https:\/\/doi.org\/10.3390\/ijms20122927.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1051_CR26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/JTO.0000000000000074","volume":"9","author":"S Champiat","year":"2014","unstructured":"Champiat S, Ileana E, Giaccone G, Besse B, Mountzios G, Eggermont A, Soria JC. Incorporating immune-checkpoint inhibitors into systemic therapy of NSCLC. J Thorac Oncol. 2014;9(2):144\u201353. https:\/\/doi.org\/10.1097\/JTO.0000000000000074.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"1051_CR27","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urolonc.2016.01.006","volume":"34","author":"AK Alme","year":"2016","unstructured":"Alme AK, Karir BS, Faltas BM, Drake CG. Blocking immune checkpoints in prostate, kidney, and urothelial cancer: an overview. Urol Oncol. 2016;34(4):171\u201381. https:\/\/doi.org\/10.1016\/j.urolonc.2016.01.006.","journal-title":"Urol Oncol"},{"issue":"9","key":"1051_CR28","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.4161\/hv.20738","volume":"8","author":"GM Mantia-Smaldone","year":"2012","unstructured":"Mantia-Smaldone GM, Corr B, Chu CS. Immunotherapy in ovarian cancer. Hum Vaccin Immunother. 2012;8(9):1179\u201391. https:\/\/doi.org\/10.4161\/hv.20738.","journal-title":"Hum Vaccin Immunother"},{"issue":"4","key":"1051_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","volume":"11","author":"AM Steitz","year":"2020","unstructured":"Steitz AM, Steffes A, Finkernagel F, Unger A, Sommerfeld L, Jansen JM, Wagner U, Graumann J, M\u00fcller R, Reinartz S. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis. 2020;11(4):249. https:\/\/doi.org\/10.1038\/s41419-020-2438-8.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1051_CR30","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.4049\/jimmunol.176.8.5023","volume":"176","author":"T Hagemann","year":"2006","unstructured":"Hagemann T, Wilson J, Burke F, Kulbe H, Li NF, Pl\u00fcddemann A, Charles K, Gordon S, Balkwill FR. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol. 2006;176(8):5023\u201332. https:\/\/doi.org\/10.4049\/jimmunol.176.8.5023.","journal-title":"J Immunol"},{"issue":"3","key":"1051_CR31","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa020177","volume":"348","author":"L Zhang","year":"2003","unstructured":"Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, Makrigiannakis A, Gray H, Schlienger K, Liebman MN, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med. 2003;348(3):203\u201313. https:\/\/doi.org\/10.1056\/NEJMoa020177.","journal-title":"N Engl J Med"},{"issue":"22","key":"1051_CR32","doi-asserted-by":"publisher","first-page":"4366","DOI":"10.1038\/s41388-019-0728-3","volume":"38","author":"B John","year":"2019","unstructured":"John B, Naczki C, Patel C, Ghoneum A, Qasem S, Salih Z, Said N. Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC. Oncogene. 2019;38(22):4366\u201383. https:\/\/doi.org\/10.1038\/s41388-019-0728-3.","journal-title":"Oncogene"},{"issue":"4","key":"1051_CR33","doi-asserted-by":"publisher","first-page":"e20191869","DOI":"10.1084\/jem.20191869","volume":"217","author":"A Etzerodt","year":"2020","unstructured":"Etzerodt A, Moulin M, Doktor TK, Delfini M, Mossadegh-Keller N, Bajenoff M, Sieweke MH, Moestru SK, Auphan-Anezin N, Lawrence T. Tissue-resident macrophages in omentum promote metastatic spread of ovarian cancer. J Exp Med. 2020;217(4):e20191869. https:\/\/doi.org\/10.1084\/jem.20191869.","journal-title":"J Exp Med"},{"issue":"2","key":"1051_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/edrv.22.2.0422","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001;22(2):255\u201388. https:\/\/doi.org\/10.1210\/edrv.22.2.0422.","journal-title":"Endocr Rev"},{"issue":"21","key":"1051_CR35","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.3390\/molecules27217523","volume":"27","author":"N Shalev","year":"2022","unstructured":"Shalev N, Kendall M, Anil SM, Tiwari S, Peeri H, Kumar N, Belausov E, Vinayaka AC, Koltai H. Phytocannabinoid compositions from Cannabis Act synergistically with PARP1 inhibitor against Ovarian Cancer cells in Vitro and affect the wnt signaling pathway. Molecules. 2022;27(21):7523. https:\/\/doi.org\/10.3390\/molecules27217523.","journal-title":"Molecules"},{"issue":"4","key":"1051_CR36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1007\/s10753-013-9620-4","volume":"36","author":"G Derosa","year":"2013","unstructured":"Derosa G, Fogari E, D\u2019Angelo A, Bianchi L, Bonaventura A, Romano D, Maffioli P. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation. 2013;36(4):914\u201320. https:\/\/doi.org\/10.1007\/s10753-013-9620-4.","journal-title":"Inflammation"},{"key":"1051_CR37","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fphar.2015.00079","volume":"6","author":"I Zagotta","year":"2015","unstructured":"Zagotta I, Dimova EY, Debatin KM, Wabitsch M, Kietzmann T, Fischer-Posovszky P. Obesity and inflammation: reduced cytokine expression due to resveratrol in a human in vitro model of inflamed adipose tissue. Front Pharmacol. 2015;6:79. https:\/\/doi.org\/10.3389\/fphar.2015.00079.","journal-title":"Front Pharmacol"},{"issue":"10","key":"1051_CR38","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1002\/cbin.11630","volume":"45","author":"J Ma","year":"2021","unstructured":"Ma J, Shayiti F, Ma J, Wei M, Hua T, Zhang R, Su J, Chen P. Tumor-associated macrophage-derived CCL5 promotes chemotherapy resistance and metastasis in prostatic cancer. Cell Biol Int. 2021;45(10):2054\u201362. https:\/\/doi.org\/10.1002\/cbin.11630.","journal-title":"Cell Biol Int"},{"key":"1051_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.canlet.2018.10.027","volume":"442","author":"Y Peng","year":"2019","unstructured":"Peng Y, Kajiyama H, Yuan H, Nakamura K, Yoshihara M, Yokoi A, Fujikake K, Yasui H, Yoshikawa N, Suzuki S, et al. PAI-1 secreted from metastatic ovarian cancer cells triggers the tumor-promoting role of the mesothelium in a feedback loop to accelerate peritoneal dissemination. Cancer Lett. 2019;442:181\u201392. https:\/\/doi.org\/10.1016\/j.canlet.2018.10.027.","journal-title":"Cancer Lett"},{"issue":"4","key":"1051_CR40","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1677\/ERC-10-0107","volume":"17","author":"C Bolitho","year":"2010","unstructured":"Bolitho C, Hahn MA, Baxter RC, Marsh DJ. The chemokine CXCL1 induces proliferation in epithelial ovarian cancer cells by transactivation of the epidermal growth factor receptor. Endocr Relat Cancer. 2010;17(4):929\u201340. https:\/\/doi.org\/10.1677\/ERC-10-0107.","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"1051_CR41","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3892\/ol.2019.10381","volume":"18","author":"F Gu","year":"2019","unstructured":"Gu F, Zhang H, Yao L, Jiang S, Lu H, Xing X, Zhang C, Jiang P, Zhang R. Leptin contributes to the taxol chemoresistance in epithelial ovarian cancer. Oncol Lett. 2019;18(1):561\u201370. https:\/\/doi.org\/10.3892\/ol.2019.10381.","journal-title":"Oncol Lett"},{"issue":"28","key":"1051_CR42","doi-asserted-by":"publisher","first-page":"e2101189118","DOI":"10.1073\/pnas.2101189118","volume":"118","author":"KW Chen","year":"2021","unstructured":"Chen KW, Demarco B, Ramos S, Heilig R, Goris M, Grayczyk JP, Assenmacher CA, Radaelli E, Joannas LD, Henao-Mejia J, et al. RIPK1 activates distinct gasdermins in macrophages and neutrophils upon pathogen blockade of innate immune signaling. Proc Natl Acad Sci U S A. 2021;118(28):e2101189118. https:\/\/doi.org\/10.1073\/pnas.2101189118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1051_CR43","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/1471-2407-14-330","volume":"14","author":"H Xu","year":"2014","unstructured":"Xu H, Lai W, Zhang Y, Liu L, Luo X, Zeng Y, Wu H, Lan Q, Chu Z. Tumor-associated macrophage-derived IL-6 and IL-8 enhance invasive activity of LoVo cells induced by PRL-3 in a KCNN4 channel-dependent manner. BMC Cancer. 2014;14:330. https:\/\/doi.org\/10.1186\/1471-2407-14-330.","journal-title":"BMC Cancer"},{"issue":"10","key":"1051_CR44","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1136\/gutjnl-2018-316324","volume":"68","author":"C Lin","year":"2019","unstructured":"Lin C, He H, Liu H, Li R, Chen Y, Qi Y, Jiang Q, Chen L, Zhang P, Zhang H, et al. Tumour-associated macrophages-derived CXCL8 determines immune evasion through autonomous PD-L1 expression in gastric cancer. Gut. 2019;68(10):1764\u201373. https:\/\/doi.org\/10.1136\/gutjnl-2018-316324.","journal-title":"Gut"}],"container-title":["Journal of Biomedical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12929-024-01051-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12929-024-01051-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T17:05:58Z","timestamp":1718125558000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbiomedsci.biomedcentral.com\/articles\/10.1186\/s12929-024-01051-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1186\/s12929-024-01051-4","relation":{},"ISSN":["1423-0127"],"issn-type":[{"value":"1423-0127","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,11]]},"assertion":[{"value":"12 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board at the Cheng Kung University Hospital (IRB number B-ER-110-484). For the animal study, the housing and experimental animal procedures were approved by the Institutional Animal Care and Use Committee of NCKU (approval number IACUC109133).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consents for publication from patients have obtained and may be requested a copy at any time.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}